Curatis Holding AG operates as a pharmaceutical company. It is engaged in the acquisition, development and commercialization of innovative medicines for the prevention, diagnosis and treatment of rare and specialty care diseases. The company was founded by Gunter Graubach and is headquartered in Liestal, Switzerland.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company